Abstract
The role of protein kinase C (PKC) on gastric H+ secretion, as measured by aminopyrine (AP) uptake and other intracellular signal transduction products, was investigated in isolated rabbit parietal cells using the PKC activator 12-0-tetradecanoyl phorbol 13-acetate (TPA) and several PKC inhibitors, including isoquinoline sulfonamides (H-7, H-8, H-89 and HA-1004) and calphostin-C. TPA dose-dependently inhibited histamine (10(-4) M)- and carbachol (10(-4) M)-stimulated AP uptake without affecting the response to dibutyryl cyclic AMP (10(-3) M). H-7 and calphostin-C dose-dependently augmented secretagogue-stimulated AP uptake, whereas H-8 and H-89 inhibited the response to secretagogues, and HA-1004 had no effect. H-7 and calphostin-C-induced augmentation of AP uptake was blocked by a calcium (Ca++) antagonist, lanthanum chloride, which suggests that the enhanced AP response was regulated by extracellular Ca++. Moreover, H-7 treatment partially reversed the TPA (10(-7) M)-induced inhibition of secretagogue-stimulated AP uptake. TPA reduced histamine- and carbachol-stimulated cAMP and inositol 1,4,5-triphosphate production by 50% and 96%, respectively, with a concomitant reduction of adenylate cyclase and intracellular free Ca++ by 44% and 78%. TPA increased the distribution of membrane-associated PKC by 20% and decreased histamine-stimulated PKA by 30%. In contrast, H-7 inhibited both PKC and protein tyrosine kinase activity in vitro but had no effect on these parameters in vivo. The results indicate that TPA-induced inhibition of secretagogue-stimulated AP uptake in PC is presumably mediated by activation of PKC.
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|